Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 6/2009

01-06-2009 | Research Articles

Long-term results of the Spanish Protocol SO-95 for the treatment of non-metastatic high-grade osteosarcoma of the extremities in children

Authors: Arturo Muñoz, José Alfaro, Nuria Pardo, Purificación García-Miguel, Víctor Quintero, Luis Gros, Carmen Melero, María Jesús Antuña, Guillermo Ocete, Jorge de las Heras, Manuel Ruiz del Portal, Ramón Huguet, María Soledad Maldonado

Published in: Clinical and Translational Oncology | Issue 6/2009

Login to get access
Metadata
Title
Long-term results of the Spanish Protocol SO-95 for the treatment of non-metastatic high-grade osteosarcoma of the extremities in children
Authors
Arturo Muñoz
José Alfaro
Nuria Pardo
Purificación García-Miguel
Víctor Quintero
Luis Gros
Carmen Melero
María Jesús Antuña
Guillermo Ocete
Jorge de las Heras
Manuel Ruiz del Portal
Ramón Huguet
María Soledad Maldonado
Publication date
01-06-2009
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 6/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-009-0373-3

Other articles of this Issue 6/2009

Clinical and Translational Oncology 6/2009 Go to the issue

Educational Series

Phosphoproteomics and cancer research

News and Views

Scientific institutes and academies

Research Articles

Biochemotherapy in the treatment of metastatic melanoma in selected patients

Educational Series

Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUP

Special Article

Guidelines for HER2 testing in breast cancer: a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM)

Case Reports

Sarcoidosis as a diagnostic pitfall of pancreatic cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits